Christopher J. BURNS,Daniel C. PEVEAR,Luigi XERRI,Timothy HENKEL,Daniel MCGARRY,Lawrence ROSEN,Gerald BRENNER,Jean-Baptiste ARLIN,Ana FERNANDEZ CASARES
申请号:
US16491116
公开号:
US20200010485A1
申请日:
2018.03.05
申请国别(地区):
US
年份:
2020
代理人:
摘要:
Described herein are crystalline forms of (R)-3-(2-(trans-4-(2-aminoethylamino)cyclohexyl)acetamido)-2-hydroxy-3,4-dihydro-2H-benzo[e][1,2]oxaborinine-8-carboxylic acid. In some embodiments, the crystalline forms are formulated for treating a subject in need thereof with a bacterial infection.